Table 2.
Sample Characteristics at Each Wave of Assessment.
| Sample Characteristics at Baseline (unless noted otherwise) |
Baseline | 3-Month | 12-Month | 24-Month |
|---|---|---|---|---|
| N (%) out of total | ||||
| Total (within each wave) | 1449 (100%) | 1164 (100%) | 1083 (100%) | 964 (100%) |
|
Responded to PROMIS SexFS domains1 (within each wave) |
332 (22.9%) | 408 (35.1%) | 768 (70.9%) | 939 (97.4%) |
| N (%) out of those who responded to PROMIS SexFS domains | ||||
| Seniority (time-specific) | ||||
| < Age 65 | 168 (50.6%) | 191 (46.8%) | 319 (41.5%) | 346 (36.8%) |
| ≥ Age 65 | 164 (49.4%) | 217 (53.2%) | 449 (58.5%) | 593 (63.2%) |
| Race | ||||
| White | 235 (70.8%) | 290 (71.1%) | 550 (71.6%) | 678 (72.2%) |
| Black | 89 (26.8%) | 109 (26.7%) | 200 (26.0%) | 229 (24.4%) |
| Asian or Pacific Islander | 0 | 1 (0.2%) | 1 (0.1%) | 2 (0.2%) |
| American Indian or Alaskan Native |
8 (2.4%) | 8 (2.0%) | 15 (2.0%) | 14 (1.5%) |
| Other & Unknown | 0 | 0 | 2 (0.3%) | 16 (1.7%) |
| Ethnicity | ||||
| Non-Hispanic | 326 (98.2%) | 402 (98.5%) | 757 (98.6%) | 914 (97.3%) |
| Hispanic | 4 (1.2%) | 3 (0.7%) | 9 (1.2%) | 10 (1.1%) |
| Unknown | 2 (0.6%) | 3 (0.7%) | 2 (0.3%) | 15 (1.6%) |
| Highest level of education | ||||
| Eighth grade or less | 18 (5.4%) | 17 (4.2%) | 23 (3.0%) | 22 (2.3%) |
| Some high school | 18 (5.4%) | 29 (7.1%) | 59 (7.7%) | 63 (6.7%) |
| High school graduate | 64 (19.3%) | 87 (21.3%) | 164 (21.4%) | 200 (21.3%) |
| Some college | 100 (30.1%) | 114 (27.9%) | 222 (28.9%) | 264 (28.1%) |
| College graduate | 132 (39.8%) | 161 (39.5%) | 300 (39.1%) | 379 (40.4%) |
| Unknown | 0 | 0 | 0 | 11 (1.2%) |
| Marital status | ||||
| Married | 265 (79.8%) | 324 (79.4%) | 625 (81.4%) | 753 (80.2%) |
| Divorced | 35 (10.5%) | 38 (9.3%) | 70 (9.1%) | 74 (7.9%) |
| Widowed | 11(3.3%) | 18(4.4%) | 31(4.0%) | 47 (5.0%) |
| Never married | 16(4.8%) | 19(4.7%) | 28(3.6%) | 35 (3.7%) |
| Separated | 5 (1.5%) | 9 (2.2%) | 14(1.8%) | 18 (1.9%) |
| Other & Unknown | 0 | 0 | 0 | 12 (1.3%) |
| Employment status | ||||
| Employed full time | 120 (36.1%) | 143 (35.0%) | 259 (33.7%) | 319 (34.0%) |
| Employed part time | 32(9.6%) | 34(8.3%) | 68(8.9%) | 77 (8.2%) |
| Unemployed | 14(4.2%) | 16(3.9%) | 26(3.4%) | 32 (3.4%) |
| Retired | 135 (40.7%) | 178 (43.6%) | 356 (46.4%) | 440 (46.9%) |
| Disabled and not working | 31(9.3%) | 37(9.1%) | 59(7.7%) | 60 (6.4%) |
| Unknown | 0 | 0 | 0 | 11 (1.2%) |
| Income | ||||
| Less than $10,000 | 15(4.5%) | 20(4.9%) | 40(5.2%) | 39 (4.2%) |
| $10,000 to $20,000 | 36(10.8%) | 43(10.5%) | 68(8.9%) | 80 (8.5%) |
| $20,001 to $40,000 | 75(22.6%) | 85(20.8%) | 162 (21.1%) | 198 (21.1%) |
| $40,001 to $70,000 | 97(29.2%) | 115 (28.2%) | 219 (28.5%) | 262 (27.9%) |
| $70,001 to $90,000 | 35(10.5%) | 50(12.3%) | 99(12.9%) | 118 (12.6%) |
| more than $90,000 | 60(18.1%) | 79(19.4%) | 153 (19.9%) | 198 (21.1%) |
| Unknown | 14(4.2%) | 16(3.9%) | 27(3.5%) | 44 (4.7%) |
| Gleason score – indicator of the aggressiveness of prostate cancer | ||||
| < 7 (slowly growing cells) | 177 (53.3%) | 230 (56.4%) | 447 (58.2%) | 537 (57.2%) |
| = 7 (intermediate risk) | 127 (38.3%) | 141 (34.6%) | 521 (67.8%) | 321 (34.2%) |
| > 7 (high grade) | 28(8.4%) | 37(9.1%) | 70(9.1%) | 81 (8.6%) |
| Treatments2 (post-baseline) | ||||
| Radiation | 119 (29.2%) | 234 (30.5%) | 285 (30.4%) | |
| Hormone with Radiation | 28(6.9%) | 65(8.5%) | 78 (8.3%) | |
| Prostatectomy | 152 (37.3%) | 278 (36.2%) | 380 (40.5%) | |
| Other treatments | 14(3.4%) | 27(3.5%) | 29 (3.1%) | |
| No treatment (e.g., active surveillance, watchful waiting, and/or supplements) |
119 (29.2%) | 228 (29.7%) | 252 (26.8%) | |
| Unknown | 6 (1.5%) | 8 (1.0%) | 7 (0.7%) | |
Note: The columns are not mutually exclusive men. The Table shows the sample size available at each assessment point.
1
Including cases with at least one response on Sexual Interest, Satisfaction with Sex Life, Orgasm, and/or Erectile Function domains of PROMIS. Therapeutic Aids is excluded because no psychometric analysis is conducted using this domain.
2
A small proportion of patients received multiple treatments.